ストックスクリーナーアプリを入手
22.22
8.69%
1.69
前日終値:
$20.53
開ける：
$20.6
24時間の取引高:
128.19K
Relative Volume:
0.44
時価総額：
$309.16M
収益：
-
当期純損益:
$-8.89M
株価収益率:
-31.74
EPS:
-0.7
ネットキャッシュフロー:
$-6.48M
1週間 パフォーマンス:
+6.21%
1か月 パフォーマンス:
+149.61%
6か月 パフォーマンス:
+121.60%
1年 パフォーマンス:
+61.59%
1日の値動き範囲:
$20.40
$22.85
1週間の範囲:
$18.54
$22.85
52週間の値動き範囲:
$7.78
$30.82
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
名前
Greenwich Lifesciences Inc
セクター
電話
203-434-3290
住所
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
GLSI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
22.32 | 284.43M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.46 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
799.09 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.99 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.29 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.39 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-20 | 開始されました | Noble Capital Markets | Outperform |
| 2021-09-01 | 開始されました | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc (GLSI) 最新ニュース
Snehal Patel Buys Handful Of Shares In Greenwich LifeSciences - simplywall.st
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Acquires 4,300 Shares - Defense World
A US$74m drop in the market cap of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is not what insiders like to see after purchasing shares recently - simplywall.st
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 4,300 Shares of Stock - MarketBeat
Head-To-Head Analysis: Greenwich LifeSciences (NASDAQ:GLSI) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Snehal Patel Purchases 2,900 Shares of Greenwich LifeSciences (NASDAQ:GLSI) Stock - Defense World
Is Lehar Footwears Limited Poised for a PostEarnings RallyVolatility Adjusted Trading & Free Exceptional Risk Adjusted Gains - earlytimes.in
Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus
Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock By Investing.com - Investing.com Nigeria
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Buys 2,900 Shares - MarketBeat
Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock - Investing.com
FY2025 Earnings Estimate for GLSI Issued By HC Wainwright - MarketBeat
How (GLSI) Movements Inform Risk Allocation Models - Stock Traders Daily
New milestone in breast cancer prevention claimed by Greenwich - The Pharma Letter
Greenwich LifeSciences extends insider share lock-up to Sept 2026 By Investing.com - Investing.com Nigeria
Greenwich LifeSciences stock soars after extending insider lock-up By Investing.com - Investing.com South Africa
Greenwich LifeSciences stock soars after extending insider lock-up - Investing.com India
What's Going On With Greenwich LifeSciences Stock Monday? - One News Page
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Greenwich LifeSciences Takes Flight As FLAMINGO 01 Breast Cancer Trial Progresses - Nasdaq
Why Did GLSI Stock Surge 25% Today? - Stocktwits
Greenwich LifeSciences extends lock-up of shares to September 2026 - marketscreener.com
Greenwich LifeSciences Extends Lock-Up Of Shares To September 2026 - TradingView — Track All Markets
Greenwich LifeSciences Extends Share Lock-Up to September For Directors, Officers - marketscreener.com
Greenwich LifeSciences extends insider share lock-up to Sept 2026 - Investing.com
Greenwich LifeSciences, Inc. Announces Extension of Lock-Up Period for Shares to September 30, 2026 - Quiver Quantitative
Biotech locks insiders out of selling stock for six years to back cancer trial - Stock Titan
Greenwich LifeSciences (NASDAQ:GLSI) Raised to "Hold" at Wall Street Zen - MarketBeat
Greenwich LifeSciences (NASDAQ:GLSI) Raised to “Hold” at Wall Street Zen - Defense World
What's Going On With Greenwich LifeSciences Friday? - Sahm
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy - Sahm
Greenwich LifeSciences provides updates on Phase III breast cancer trial By Investing.com - Investing.com Nigeria
Greenwich Life Sciences Provides Updates On Breast Cancer Study; Outlines Corporate Strategy - Nasdaq
Greenwich LifeSciences says burn rate for 2025 $7M through first three quarters - TipRanks
Greenwich LifeSciences provides updates on Phase III breast cancer trial - Investing.com
Greenwich LifeSciences Provides Updates on Phase III FLAMINGO-01 Clinical Trial and Corporate Strategy - Quiver Quantitative
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Buys $51,742.00 in Stock - Defense World
How strong is Greenwich LifeSciences Inc. stock revenue growth2025 Retail Activity & Fast Gaining Stock Strategy Reports - bolumsonucanavari.com
Why Greenwich LifeSciences Inc. stock is a must watch in 2025Profit Target & Low Risk High Reward Trade Ideas - Улправда
(GLSI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Aug PreEarnings: Will Greenwich LifeSciences Inc. stock maintain momentum in 2025 - Улправда
Will Greenwich LifeSciences Inc. stock maintain momentum in 2025July 2025 Sector Moves & Capital Efficiency Focused Strategies - Улправда
Noble Financial Sticks to Their Buy Rating for Greenwich LifeSciences (GLSI) - The Globe and Mail
Is Greenwich LifeSciences Inc. stock positioned well for digital economyQuarterly Earnings Report & Technical Pattern Based Signals - Улправда
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases 4,100 Shares of Stock - MarketBeat
Will Greenwich LifeSciences Inc. stock outperform growth indexes2025 Trading Volume Trends & Low Volatility Stock Recommendations - DonanımHaber
Will Greenwich LifeSciences Inc. stock benefit from upcoming earnings reports2025 Bull vs Bear & Free Low Drawdown Momentum Trade Ideas - Улправда
Greenwich LifeSciences Stockholders Reelect Board and Auditor - TipRanks
Greenwich Lifesciences Inc (GLSI) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):